Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rebamipide as an Adjunct to Methotrexate in Patients With Active Rheumatoid Arthritis

NCT05166304 is registered in ClinicalTrials.gov with October 6 University as lead sponsor.

NCT NCT05166304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05166304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rebamipide as an Adjunct to Methotrexate in Patients With Active Rheumatoid Arthritis
Lead sponsor
October 6 University
Phase
Phase 1/2
Overall status
Completed
Start date
January 1, 2024
Completion date
September 1, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis